|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2200064473 |
|
最近更新日期: Date of Last Refreshed on: |
2022-10-09 18:17:42 |
|
注册时间: Date of Registration: |
2022-10-09 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
母乳成分与早产儿健康的关联研究 |
|
Public title: |
Study on the relationship between the composition of breast milk and the health of premature infants |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
母乳成分与早产儿生长发育及肠道健康的关联研究 |
|
Scientific title: |
Study on the relationship between the composition of breast milk and the development or intestinal health of premature infants |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
郭潇潇 |
研究负责人: |
罗小琴 |
|
Applicant: |
Guo Xiaoxiao |
Study leader: |
Luo Xiaoqin |
|
申请注册联系人电话: Applicant telephone: |
17765884315 |
研究负责人电话:
Study leader's |
18802932796 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
guoxiaoxiao723@163.com |
研究负责人电子邮件: Study leader's E-mail: |
luoxiaoqin2012@mail.xjtu.edu.cn |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
陕西省咸阳市秦都区西安交通大学创新港C区 |
研究负责人通讯地址: |
陕西省西安市雁塔西路76号 |
|
Applicant address: |
Area C, Innovation Harbor, Xi'an Jiaotong University, Qindu District, Xianyang, Shaanxi |
Study leader's address: |
76 Yanta Road West, Xi'an, Shaanxi |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
西安交通大学 |
||
|
Applicant's institution: |
Xi'an Jiaotong University |
||
|
研究负责人所在单位: |
西安交通大学 |
||
|
Affiliation of the Leader: |
Xi'an Jiaotong University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2022-1486 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
西安交通大学医学部生物医学伦理委员会 |
||
|
Name of the ethic committee: |
Biomedical Ethics Committee of Medical Department of Xi'an Jiaotong University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2022-09-14 00:00:00 | ||
|
伦理委员会联系人: |
耿老师 |
||
|
Contact Name of the ethic committee: |
Teacher Geng |
||
|
伦理委员会联系地址: |
西安交通大学医学部科技处 |
||
|
Contact Address of the ethic committee: |
Science and Technology Division of Medical Department of Xi'an Jiaotong University |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
82657512 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
西安交通大学 |
||||||||||||||||||||||
|
Primary sponsor: |
Xi'an Jiaotong University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
陕西省西安市雁塔西路76号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
76 Yanta Road West, Xi'an, Shaanxi |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
横向课题:HXDSH20221514 |
||||||||||||||||||||||
|
Source(s) of funding: |
HXDSH20221514 |
||||||||||||||||||||||
|
研究疾病: |
早产儿 |
||||||||||||||||||||||
|
Target disease: |
premature infant |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
队列研究 |
||||||||||||||||||||||
|
Study design: |
Cohort study |
||||||||||||||||||||||
|
研究目的: |
项目将收集母乳和婴儿粪便,并采用随访、问卷调查、体格测量、肠道菌群检测、认知发育评估等调查方法探究早产儿母乳特定活性成分与健康关联。 |
||||||||||||||||||||||
|
Objectives of Study: |
The project will collect breast milk and infant feces, and use follow-up, questionnaire, physical measurement, intestinal flora detection, cognitive development evaluation and other survey methods to explore the relationship between specific active components of premature infants' breast milk and health. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1)产妇纳入标准:产后计划在西安长期居住、年龄20-35周岁、计划母乳喂养或混合喂养,父母一方或双方和/或根据当地法律法定监护人提供的书面知情同意。其排除标准:高血压、糖尿病、慢性肝炎、慢性肾炎、精神疾病、吸烟、通过辅助生殖技术孕育双胞胎或多胞胎或婴儿的母亲。 |
||||||||||||||||||||||
|
Inclusion criteria |
1) Inclusion criteria for puerpera: Written informed consent provided by one or both parents and/or legal guardian according to local laws for long-term residence in Xi'an, 20-35 years of age, planned breastfeeding or mixed feeding. The exclusion criteria are: hypertension, diabetes, chronic hepatitis, chronic nephritis, mental illness, smoking, mothers who conceive twins or multiple births or babies through assisted reproductive technology. |
||||||||||||||||||||||
|
排除标准: |
新生儿和产妇入组研究前2周内,参加任何其他涉及试验用产品或已上市产品的研究不得纳入。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Any other research involving trial products or marketed products shall not be included within 2 weeks before the newborn and puerpera are included in the study. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2022-10-08 00:00:00至 To 2023-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2022-10-08 00:00:00 至 To 2023-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
研究小组利用spss随机数字生成器分组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
The research team will use SPSS random number generator to group. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
文章发表后12个月 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
6 months after papper published |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
利用Excel进行数据采集和管理 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Use Excel software for data collection and management. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |